Exact Mass: 519.2805182
Exact Mass Matches: 519.2805182
Found 169 metabolites which its exact mass value is equals to given mass value 519.2805182
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
[(3S,5S,7S)-7-{(1E,3E)-5-[(2S,3S,5R,6R)-5-{[(2Z,4S)-4-(acetyloxy)pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl]-3-methylpenta-1,3-dien-1-yl}-1,6-dioxaspiro[2.5]oct-5-yl]acetic acid
[(2S,5S,6R)-6-{(1E,3E)-5-[(2S,3S,5R,6R)-5-{[(2Z,4S)-4-(acetyloxy)pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl]-3-methylpenta-1,3-dien-1-yl}-5-hydroxy-4-methylidenetetrahydro-2H-pyran-2-yl]acetic acid
4,5-dihydro-7-O-descarbamoyl-7-hydroxygeldanamycin
Glu Ile Lys Met
Glu Ile Met Lys
Glu Lys Ile Met
Glu Lys Leu Met
Glu Lys Met Ile
Glu Lys Met Leu
Glu Leu Lys Met
Glu Leu Met Lys
Glu Met Ile Lys
Glu Met Lys Ile
Glu Met Lys Leu
Glu Met Leu Lys
Phe Pro Arg Thr
Phe Pro Thr Arg
Phe Arg Pro Thr
Phe Arg Thr Pro
Phe Thr Pro Arg
Phe Thr Arg Pro
Ile Glu Lys Met
Ile Glu Met Lys
Ile Lys Glu Met
Ile Lys Met Glu
Ile Met Glu Lys
Ile Met Lys Glu
Ile Met Arg Thr
C21H41N7O6S (519.2838886000001)
Ile Met Thr Arg
C21H41N7O6S (519.2838886000001)
Ile Arg Met Thr
C21H41N7O6S (519.2838886000001)
Ile Arg Thr Met
C21H41N7O6S (519.2838886000001)
Ile Thr Met Arg
C21H41N7O6S (519.2838886000001)
Ile Thr Arg Met
C21H41N7O6S (519.2838886000001)
Lys Glu Ile Met
Lys Glu Leu Met
Lys Glu Met Ile
Lys Glu Met Leu
Lys Ile Glu Met
Lys Ile Met Glu
Lys Lys Met Asn
C21H41N7O6S (519.2838886000001)
Lys Lys Asn Met
C21H41N7O6S (519.2838886000001)
Lys Leu Glu Met
Lys Leu Met Glu
Lys Met Glu Ile
Lys Met Glu Leu
Lys Met Ile Glu
Lys Met Lys Asn
C21H41N7O6S (519.2838886000001)
Lys Met Leu Glu
Lys Met Asn Lys
C21H41N7O6S (519.2838886000001)
Lys Asn Lys Met
C21H41N7O6S (519.2838886000001)
Lys Asn Met Lys
C21H41N7O6S (519.2838886000001)
Leu Glu Lys Met
Leu Glu Met Lys
Leu Lys Glu Met
Leu Lys Met Glu
Leu Met Glu Lys
Leu Met Lys Glu
Leu Met Arg Thr
C21H41N7O6S (519.2838886000001)
Leu Met Thr Arg
C21H41N7O6S (519.2838886000001)
Leu Arg Met Thr
C21H41N7O6S (519.2838886000001)
Leu Arg Thr Met
C21H41N7O6S (519.2838886000001)
Leu Thr Met Arg
C21H41N7O6S (519.2838886000001)
Leu Thr Arg Met
C21H41N7O6S (519.2838886000001)
Met Glu Ile Lys
Met Glu Lys Ile
Met Glu Lys Leu
Met Glu Leu Lys
Met Ile Glu Lys
Met Ile Lys Glu
Met Ile Arg Thr
C21H41N7O6S (519.2838886000001)
Met Ile Thr Arg
C21H41N7O6S (519.2838886000001)
Met Lys Glu Ile
Met Lys Glu Leu
Met Lys Ile Glu
Met Lys Lys Asn
C21H41N7O6S (519.2838886000001)
Met Lys Leu Glu
Met Lys Asn Lys
C21H41N7O6S (519.2838886000001)
Met Leu Glu Lys
Met Leu Lys Glu
Met Leu Arg Thr
C21H41N7O6S (519.2838886000001)
Met Leu Thr Arg
C21H41N7O6S (519.2838886000001)
Met Asn Lys Lys
C21H41N7O6S (519.2838886000001)
Met Arg Ile Thr
C21H41N7O6S (519.2838886000001)
Met Arg Leu Thr
C21H41N7O6S (519.2838886000001)
Met Arg Thr Ile
C21H41N7O6S (519.2838886000001)
Met Arg Thr Leu
C21H41N7O6S (519.2838886000001)
Met Thr Ile Arg
C21H41N7O6S (519.2838886000001)
Met Thr Leu Arg
C21H41N7O6S (519.2838886000001)
Met Thr Arg Ile
C21H41N7O6S (519.2838886000001)
Met Thr Arg Leu
C21H41N7O6S (519.2838886000001)
Asn Lys Lys Met
C21H41N7O6S (519.2838886000001)
Asn Lys Met Lys
C21H41N7O6S (519.2838886000001)
Asn Met Lys Lys
C21H41N7O6S (519.2838886000001)
Pro Phe Arg Thr
Pro Phe Thr Arg
Pro Arg Phe Thr
Pro Arg Thr Phe
Pro Thr Phe Arg
Pro Thr Arg Phe
Arg Phe Pro Thr
Arg Phe Thr Pro
Arg Ile Met Thr
C21H41N7O6S (519.2838886000001)
Arg Ile Thr Met
C21H41N7O6S (519.2838886000001)
Arg Leu Met Thr
C21H41N7O6S (519.2838886000001)
Arg Leu Thr Met
C21H41N7O6S (519.2838886000001)
Arg Met Ile Thr
C21H41N7O6S (519.2838886000001)
Arg Met Leu Thr
C21H41N7O6S (519.2838886000001)
Arg Met Thr Ile
C21H41N7O6S (519.2838886000001)
Arg Met Thr Leu
C21H41N7O6S (519.2838886000001)
Arg Pro Phe Thr
Arg Pro Thr Phe
Arg Thr Phe Pro
Arg Thr Ile Met
C21H41N7O6S (519.2838886000001)
Arg Thr Leu Met
C21H41N7O6S (519.2838886000001)
Arg Thr Met Ile
C21H41N7O6S (519.2838886000001)
Arg Thr Met Leu
C21H41N7O6S (519.2838886000001)
Arg Thr Pro Phe
Thr Phe Pro Arg
Thr Phe Arg Pro
Thr Ile Met Arg
C21H41N7O6S (519.2838886000001)
Thr Ile Arg Met
C21H41N7O6S (519.2838886000001)
Thr Leu Met Arg
C21H41N7O6S (519.2838886000001)
Thr Leu Arg Met
C21H41N7O6S (519.2838886000001)
Thr Met Ile Arg
C21H41N7O6S (519.2838886000001)
Thr Met Leu Arg
C21H41N7O6S (519.2838886000001)
Thr Met Arg Ile
C21H41N7O6S (519.2838886000001)
Thr Met Arg Leu
C21H41N7O6S (519.2838886000001)
Thr Pro Phe Arg
Thr Pro Arg Phe
Thr Arg Phe Pro
Thr Arg Ile Met
C21H41N7O6S (519.2838886000001)
Thr Arg Leu Met
C21H41N7O6S (519.2838886000001)
Thr Arg Met Ile
C21H41N7O6S (519.2838886000001)
Thr Arg Met Leu
C21H41N7O6S (519.2838886000001)
Thr Arg Pro Phe
ibha#22
A 4-O-(1H-indol-3-ylcarbonyl)ascaroside that is icas#22 in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
ibho#22
An omega-hydroxy fatty acid ascaroside that is bhos#22 in which the hydroxy group at position 4 of the ascarylopyranose moiety has been has been converted to the corresponding 1H-indole-3-carboxylate ester. It is a metabolite of the nematode Caenorhabditis elegans.
Bomedemstat
C28H34FN7O2 (519.2757876000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(3R)-13-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]-3-hydroxytridecanoic acid
(3R,12R)-12-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]-3-hydroxytridecanoic acid
N-[[(4R,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
C27H41N3O5S (519.2766776000001)
N-[[(4S,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
C27H41N3O5S (519.2766776000001)
N-[[(4S,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
C27H41N3O5S (519.2766776000001)
N-[[(4S,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
C27H41N3O5S (519.2766776000001)
N-[[(4R,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
C27H41N3O5S (519.2766776000001)
N-[[(4R,5S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
C27H41N3O5S (519.2766776000001)
N-[[(4S,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
C27H41N3O5S (519.2766776000001)
N-[[(4R,5R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclohexanecarboxamide
C27H41N3O5S (519.2766776000001)
N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(3-phenylprop-1-ynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
KRAS inhibitor-10
KRAS inhibitor-10 (compound 11) selectively and effectively inhibit RAS proteins, and particularly KRAS proteins. KRAS inhibitor-10 is an orally active anti-cancer agent and can be used for cancer research, such as pancreatic cancer, breast cancer, multiple myeloma, leukemia and lung cancer. KRAS inhibitor-10 is a?tetrahydroisoquinoline compound (compound 11) extracted from patent WO2021005165 A1[1].